Tang Z, Louie R F, Lee J H, Lee D M, Miller E E, Kost G J
Point-of-Care Testing Center for Teaching and Research, University of California, Davis, CA, USA.
Crit Care Med. 2001 May;29(5):1062-70. doi: 10.1097/00003246-200105000-00038.
To determine the effects of different oxygen tensions (Po2) on glucose measurements with glucose dehydrogenase (GD)-based and glucose oxidase (GO)-based test strips, to quantitate changes in glucose measurements observed with different Po2 levels, and to discuss the potential risks of oxygen-derived glucose errors in critical care.
Venous blood from healthy volunteers was tonometered to create different oxygen tensions simulating patient arterial Po2 levels. Venous blood from diabetic patients was exposed to air to alter oxygen tensions simulating changes in Po2 during sample handling. Whole-blood glucose measurements obtained from these samples with six glucose meters were compared with reference analyzer plasma glucose measurements. Glucose differences were plotted vs. different Po2 levels to identify error trends. Error tolerances were as follows: a) within +/-15 mg/dL of the reference measurement for glucose levels <or=100 mg/dL; and b) within +/-15% of the reference measurement for glucose levels >100 mg/dL.
Five healthy volunteers in the bench study and 11 diabetic patients in the clinical study.
In the bench study, increases in Po2 levels decreased glucose measured with GO-based amperometric test strips, mainly at Po2 levels >100 torr. At nearly constant glucose concentrations, glucose meter systems showed large variations at low (39 torr) vs. high (396 torr) Po2 levels. Glucose measured with GD-based amperometric and GO-based photometric test strips generally were within error tolerances. In the clinical study, 31.6% (Precision PCx), 20.2% (Precision QID), and 23.0% (Glucometer Elite) of glucose measurements with GO-based amperometric test strips, 14.3% (SureStep) of glucose measurements with GO-based photometric test strips, and 4.6% (Accu-Chek Advantage H) and 5.9% (Accu-Chek Comfort Curve) of glucose measurements with GD-based amperometric test strips were out of the error tolerances.
Different oxygen tensions do not significantly affect glucose measured with the GD-based amperometric test strips, and have minimal effect on GO-based photometric test strips. Increases in oxygen tension lowered glucose measured with GO-based amperometric test strips. We recommend that the effects of different oxygen tensions in blood samples on glucose measurements be minimized by using oxygen-independent test strips for point-of-care glucose testing in critically ill and other patients with high or unpredictable blood Po2 levels.
确定不同氧分压(Po2)对基于葡萄糖脱氢酶(GD)和基于葡萄糖氧化酶(GO)的测试条测量葡萄糖的影响,量化在不同Po2水平下观察到的葡萄糖测量变化,并讨论重症监护中氧源性葡萄糖误差的潜在风险。
将健康志愿者的静脉血进行血气分析,以创建模拟患者动脉Po2水平的不同氧分压。将糖尿病患者的静脉血暴露于空气中,以改变氧分压,模拟样本处理过程中Po2的变化。使用六台血糖仪从这些样本中获得的全血葡萄糖测量值与参考分析仪测量的血浆葡萄糖值进行比较。绘制葡萄糖差异与不同Po2水平的关系图,以确定误差趋势。误差容限如下:a)葡萄糖水平≤100mg/dL时,在参考测量值的±15mg/dL范围内;b)葡萄糖水平>100mg/dL时,在参考测量值的±15%范围内。
基础研究中有5名健康志愿者,临床研究中有11名糖尿病患者。
在基础研究中,Po2水平升高会降低基于GO的电流型测试条测量的葡萄糖值,主要在Po2水平>100托时。在葡萄糖浓度几乎恒定的情况下,血糖仪系统在低(39托)与高(396托)Po2水平下显示出较大差异。基于GD的电流型测试条和基于GO的光度型测试条测量的葡萄糖值通常在误差容限内。在临床研究中,基于GO的电流型测试条测量的葡萄糖值中,31.6%(Precision PCx)、20.2%(Precision QID)和23.0%(Glucometer Elite)超出误差容限;基于GO的光度型测试条测量的葡萄糖值中,14.3%(SureStep)超出误差容限;基于GD的电流型测试条测量的葡萄糖值中,4.6%(Accu-Chek Advantage H)和5.9%(Accu-Chek Comfort Curve)超出误差容限。
不同氧分压对基于GD的电流型测试条测量的葡萄糖值影响不显著,对基于GO的光度型测试条影响最小。氧分压升高会降低基于GO的电流型测试条测量的葡萄糖值。我们建议,对于重症患者和其他血液Po2水平高或不可预测的患者,在进行即时护理葡萄糖检测时,应使用不依赖氧的测试条,以尽量减少血样中不同氧分压对葡萄糖测量的影响。